Custom Search

Register
Sign In
Sign In Using Facebook

Thailand Scraps Patent Override on Cancer Drug With Novartis

February 02, 2008 at 4:09 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
Thailand will not override a patent on leukaemia drug Glivec after its maker, Swiss giant Novartis, agreed to give the medicine to most patients for free, an official said Friday.
Thailand Scraps Patent Override on Cancer Drug With Novartis


The move was a last-minute victory for the outgoing military-backed government, which was at loggerheads with Western pharmaceutical firms over so-called compulsory licenses, which temporarily suspend patent protections.

The government already overrode patents for popular heart drug Plavix and two key AIDS medicines -- Kaletra and Efavirenz -- and has threatened to expand its generic programmes to include cancer drugs, including Glivec.

But Novartis has agreed to give Glivec to Thai patients for free, said Suchart Chongtrasert, a senior official at the Food and Drug Administration and a member of Thailand's generic drug negotiation team.

"The company agreed to give the medicine to Thai patients for free. We are satisfied with the outcome. With the company's proposal, there is no need to do CL," Suchart said, referring to compulsory licenses.

Thai cancer patients with an annual household income of less than 1.7 million baht (51,000 dollars) are eligible to receive free Glivec, he said.

Currently, Glivec, which is also known as Imatinib, costs 130,000 baht (4,000 dollars) per patient per month, the ministry said.

As Thailand's newly-elected Prime Minister Samak Sundaravej is set to form his cabinet early next week, Suchart said he hoped the new government would continue to press ahead with generic drug programmes.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Oncology - Focus on Cancer Prevention
News Archive
Date :
Category :
Keyword :
Quiz on Cancer
Looking for information on cancer? Go through medindia's Cancer quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Cancer
Complete Medindia Resources
News Categories:  
Diabetes Health Center

Drug Related News

» Research Says Financial Burden of Prescription Drugs is Dropping » New Guidelines to Avoid Heparin Contamination
» Weight Loss Drug Has Killed At Least 1,300 in France » FDA Approves Sanofi’s Treatment for Head Lice
» New Scoring Method may Help Decide Who Will Benefit From Stroke Drug » New Guidelines Recommend Metformin to Treat Type 2 Diabetes
» Novel Prostate Cancer Drug Target Identified » Aspirin Helps Prevent DVT
Read More >>